User profiles for HIDESAKU ASAKURA
Hidesaku ASAKURAKanazawa University Hospital Verified email at staff.kanazawa-u.ac.jp Cited by 8318 |
[HTML][HTML] COVID-19-associated coagulopathy and disseminated intravascular coagulation
The pathology of coronavirus disease 2019 (COVID-19) is exacerbated by the progression
of thrombosis, and disseminated intravascular coagulation (DIC), and cytokine storms. The …
of thrombosis, and disseminated intravascular coagulation (DIC), and cytokine storms. The …
Expert consensus for the treatment of disseminated intravascular coagulation in Japan
The present report from The Japanese Society of Thrombosis and Hemostasis provides an
expert consensus for the treatment of disseminated intravascular coagulation (DIC) in Japan. …
expert consensus for the treatment of disseminated intravascular coagulation (DIC) in Japan. …
[HTML][HTML] Classifying types of disseminated intravascular coagulation: clinical and animal models
H Asakura - Journal of intensive care, 2014 - Springer
Disseminated intravascular coagulation (DIC) has a common pathogenesis in terms of
persistent widespread activation of coagulation in the presence of underlying disease, but the …
persistent widespread activation of coagulation in the presence of underlying disease, but the …
[HTML][HTML] Proposal for new diagnostic criteria for DIC from the Japanese Society on Thrombosis and Hemostasis
H Asakura, H Takahashi, T Uchiyama, Y Eguchi… - Thrombosis …, 2016 - Springer
Disseminated intravascular coagulation (DIC) is a serious disease that, in the presence of
underlying disease, causes persistent, generalized, marked coagulation activation. Early …
underlying disease, causes persistent, generalized, marked coagulation activation. Early …
Comparison of diagnostic criteria for disseminated intravascular coagulation (DIC): diagnostic criteria of the International Society of Thrombosis and Hemostasis (ISTH …
H Wada, EC Gabazza, H Asakura… - American journal of …, 2003 - Wiley Online Library
We compared the criteria set by the International Society of Thrombosis and Hemostasis (ISTH)
for the diagnosis of disseminated intravascular coagulation (DIC) with the criteria of the …
for the diagnosis of disseminated intravascular coagulation (DIC) with the criteria of the …
Potential of heparin and nafamostat combination therapy for COVID‐19
Tang et al recently reported that, in COVID-19 infections caused by the novel coronavirus (SARS-CoV-2),
heparin anticoagulant therapy lowers the mortality rate in patients who present …
heparin anticoagulant therapy lowers the mortality rate in patients who present …
[HTML][HTML] Thrombomodulin in disseminated intravascular coagulation and other critical conditions—a multi-faceted anticoagulant protein with therapeutic potential
Thrombomodulin plays a vital role in maintaining intravascular patency due to its anticoagulant,
antiinflammatory, and cytoprotective properties. However, under pathological conditions …
antiinflammatory, and cytoprotective properties. However, under pathological conditions …
Evaluation of new Japanese diagnostic criteria for disseminated intravascular coagulation in critically ill patients
New Japanese diagnostic criteria were prepared for disseminated intravascular coagulation
(DIC) in critically ill patients and their usefulness was compared with the criteria of the …
(DIC) in critically ill patients and their usefulness was compared with the criteria of the …
A comparative double-blind randomized trial of activated protein C and unfractionated heparin in the treatment of disseminated intravascular coagulation
…, H Takahashi, J Takamatsu, H Asakura… - International journal of …, 2002 - Springer
A randomized prospective double-blind trial was performed to compare the safety and
efficacy of human activated protein C (APC) and unfractionated heparin for the treatment of …
efficacy of human activated protein C (APC) and unfractionated heparin for the treatment of …
[HTML][HTML] Coagulopathy and fibrinolytic pathophysiology in COVID-19 and SARS-CoV-2 vaccination
S Yamada, H Asakura - International Journal of Molecular Sciences, 2022 - mdpi.com
Coronavirus Disease 2019 (COVID-19) is caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) and is frequently complicated by thrombosis. In some cases of …
coronavirus 2 (SARS-CoV-2) and is frequently complicated by thrombosis. In some cases of …